Infections in patients with aplastic anemia
- PMID: 19549579
- DOI: 10.1053/j.seminhematol.2009.03.008
Infections in patients with aplastic anemia
Abstract
Infection is a major cause of death in patients with aplastic anemia (AA). There are differences between the immunocompromised state of a patient with AA and the patient who is neutropenic due to chemotherapy and this leads to a difference in the infections that they incur. Prolonged neutropenia is one of the largest risk factors for the development of infections with the invasive mycoses and bacteria. Recovery from neutropenia is directly related to survival, and supportive care plays a large role in protection while the patient is in a neutropenic state. The most common invasive mycoses include the Aspergillus species, Zygomycetes, Candida spp., and Fusarium spp. Bacterial infections that are seen in patients with AA include gram-positive coagulase-negative Staphylococcus species, Enterococcus, Staphylococus aureus, Clostridium spp., Micrococcus, alpha-hemolytic streptococci, Listeria monocytogenes, and Bacillus cereus. Gram-negative infections including gram-negative bacilli, Escherichia coli, Salmonella, Bacteroides fragilis, Klebsiella oxytoca, Klebsiella pneumonia, Aeromonas hydrophilia, Pseudomonas aeruginosa, and Vibrio vulnificus. Viral infections are much less common but include those that belong to the Herpesviridae family, community-acquired respiratory viral infection, and the viral hepatitides A, B, and C. Evidence of the parasite Strongyloides stercoralis has also been documented. This review discusses the major invasive fungal infections, bacterial pathogens, parasites, and viral infections that are found in patients with AA who are treated with immunosuppressive therapy. The specific immune impairment and current treatment parameters for each of these classes of infection will also be discussed.
Similar articles
-
[Infections of the central nervous system in malignant hemopathies].Rev Neurol (Paris). 1986;142(2):116-25. Rev Neurol (Paris). 1986. PMID: 3726388 French.
-
Infections in patients with aplastic anemia: experience at a tertiary care cancer center.Cancer. 2003 Jul 1;98(1):86-93. doi: 10.1002/cncr.11478. Cancer. 2003. PMID: 12833460
-
Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis.Clin Ther. 1985;8(1):90-9. Clin Ther. 1985. PMID: 3914372
-
Gastrointestinal infections in the immunocompromised host.Curr Opin Gastroenterol. 2005 Jan;21(1):39-43. Curr Opin Gastroenterol. 2005. PMID: 15687883 Review.
-
Approach to management of fever and infection in patients with primary bone marrow failure and hemoglobinopathies.Hematol Oncol Clin North Am. 1993 Aug;7(4):865-85. Hematol Oncol Clin North Am. 1993. PMID: 8354659 Review.
Cited by
-
Recognition and prevention of hospital-associated enteric infections in the intensive care unit.Crit Care Med. 2010 Aug;38(8 Suppl):S324-34. doi: 10.1097/CCM.0b013e3181e69f05. Crit Care Med. 2010. PMID: 20647790 Free PMC article. Review.
-
Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment.J Patient Rep Outcomes. 2017;2(1):13. doi: 10.1186/s41687-018-0032-y. Epub 2018 Mar 1. J Patient Rep Outcomes. 2017. PMID: 29757294 Free PMC article.
-
[Clinical analysis of 76 patients with severe aplastic anemia treated with haploid hematopoietic stem cell transplantation].Zhonghua Xue Ye Xue Za Zhi. 2023 Mar 14;44(3):202-210. doi: 10.3760/cma.j.issn.0253-2727.2023.03.005. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 37356981 Free PMC article. Chinese.
-
Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT).Bone Marrow Transplant. 2021 Oct;56(10):2518-2532. doi: 10.1038/s41409-021-01332-8. Epub 2021 May 19. Bone Marrow Transplant. 2021. PMID: 34011966 Review.
-
Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.Antimicrob Agents Chemother. 2016 Apr 22;60(5):2718-26. doi: 10.1128/AAC.02665-15. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 26883703 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous